Buy InVivo Therapeutics Stock | NVIV Stock Price & Latest News | Public
NVIV

InVivo Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About NVIV

    Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Sp...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -3
    -6
    -9
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$4.80

    Actual EPS
    Q3 2020

    Stats

    Market Cap$7,07M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$17.70
    1 Year Low$1.08
    Open$1.40
    High$1.46
    Low$1.40

    Buy any stock with any amount of money.

    Download the App
    Download the app